Naturalendo Tech Co Ltd

Naturalendo’s capital structure shows a debt-to-equity ratio of 0.39, indicating moderate leverage, and a current ratio of 1.92, suggesting acceptable short-term liquidity. However, the company’s operating cash flow is negative at -5.66 billion KRW, and free cash flow is also negative at -2.94 billion KRW, signaling cash flow constraints. Profitability metrics are weak, with a return on equity of -13.44% and return on assets of -8.99%, both significantly below the industry median for Personal Products, which typically shows positive returns. The company is currently unprofitable, with a net loss of 3.22 billion KRW and an operating loss of 3.52 billion KRW. The company operates through two segments: Cosmeceutical and Health Functional Food. The Cosmeceutical segment focuses on skincare and anti-aging products, while the Health Functional Food segment includes enzyme and diet products. Revenue concentration data is not disclosed, but the company operates in both domestic and international markets. Growth appears constrained, with no disclosed revenue growth in the latest period. The company reported revenue of 22.23 billion KRW, but operating and net losses persist. No forward-looking revenue growth is provided in the outlook. Risk factors include liquidity concerns due to negative operating and free cash flows, and a net cash position that is negative after subtracting total debt. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. Recent events include the company’s continued focus on its core healthcare and cosmeceutical products, with no major acquisitions or divestitures disclosed in the latest financial snapshot. The company remains active in both domestic and international markets.